cached image

Guillaume Hache

Pharmacology EA3544, Châtenay-Malabry, Île-de-France, France 
"Guillaume Hache"
Mean distance: 16.44 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hache G, Guiard BP, Nguyen TH, et al. (2015) Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain. European Journal of Pain (London, England). 19: 322-33
Le Dantec Y, Hache G, Guilloux JP, et al. (2014) NREM sleep hypersomnia and reduced sleep/wake continuity in a neuroendocrine mouse model of anxiety/depression based on chronic corticosterone administration. Neuroscience. 274: 357-68
Massicot F, Hache G, David L, et al. (2013) P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach. Plos One. 8: e66830
Dantec YL, Hache G, Quesseveur G, et al. (2013) Caractérisation des altérations veille/sommeil dans un modèle murin neuroendocrinien d’anxiété/dépression Neurophysiologie Clinique-Clinical Neurophysiology. 10: 117
Gorsane MA, Kebir O, Hache G, et al. (2012) Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Substance Abuse. 33: 336-49
Hache G, Guiard BP, Le Dantec Y, et al. (2012) Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression. Neuroreport. 23: 525-9
Hache G, Coudore F, Gardier AM, et al. (2011) Monoaminergic antidepressants in the relief of pain: Potential therapeutic utility of triple reuptake inhibitors (TRIs) Pharmaceuticals. 4: 285-342
See more...